Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

ROSIGLITAZONE MALEATE AND METFORMIN HYDROCHLORIDE

METFORMIN HYDROCHLORIDE; ROSIGLITAZONE MALEATE

Standard Dose
1GM;EQ 4MG BASE
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview ROSIGLITAZONE MALEATE AND METFORMIN HYDROCHLORIDE is listed in Drugs@FDA under application 077337 (ANDA).

Marketing status: Discontinued Active ingredient METFORMIN HYDROCHLORIDE; ROSIGLITAZONE MALEATE Form and strength TABLET;ORAL - 1GM;EQ 4MG BASE Sponsor TEVA Submission history Latest submission status date: 2017-05-19 00:00:00.

Structured Monograph

Clinical summary

Approval overview ROSIGLITAZONE MALEATE AND METFORMIN HYDROCHLORIDE is listed in Drugs@FDA under application 077337 (ANDA). Marketing status: Discontinued Active ingredient METFORMIN HYDROCHLORIDE; ROSIGLITAZONE MALEATE Form and strength TABLET;ORAL - 1GM;EQ 4MG BASE Sponsor TEVA Submission history Latest submission status date: 2017-05-19 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.